Targeting the epigenome in in-stent restenosis: from mechanisms to therapy

Coronary artery disease (CAD) is one of the most common causes of death worldwide. The introduction of percutaneous revascularization has revolutionized the therapy of patients with CAD. Despite the advent of drug-eluting stents, restenosis remains the main challenge in treating patients with CAD. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xi, Yang, Yanyan, Guo, Junjie, Meng, Yuanyuan, Li, Min, Yang, Panyu, Liu, Xin, Aung, Lynn Htet Htet, Yu, Tao, Li, Yonghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896131/
https://www.ncbi.nlm.nih.gov/pubmed/33664994
http://dx.doi.org/10.1016/j.omtn.2021.01.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896131/
https://www.ncbi.nlm.nih.gov/pubmed/33664994
http://dx.doi.org/10.1016/j.omtn.2021.01.024

Ejemplares similares